UBS keeps GSK at 'neutral' with focus on chief executive's strategy update
UBS keeps GSK at 'neutral' with focus on chief executive's strategy update
UBS keeps GSK at 'neutral' with focus on chief executive's strategy update
Summary aggregated from Yahoo Finance's public RSS feed. The full reporting belongs to Yahoo Finance — please read it on their site.